Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia
Clinical trial NCT02631252 · TERMINATED
Trial details
- NCT number
- NCT02631252
- Sponsor
- Alison Sehgal, MD, MS
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-18
- Primary completion
- 2016-09-17
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.